Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer.
暂无分享,去创建一个
Hedvig Hricak | H. Hricak | A. Westphalen | F. Coakley | A. Qayyum | B. Powell | Aliya Qayyum | Antonio C Westphalen | Fergus V Coakley | Bethan Powell | William T Okuno | W. Okuno
[1] F. Coakley. Staging ovarian cancer: role of imaging. , 2002, Radiologic clinics of North America.
[2] H. Hricak,et al. Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. , 2002, Radiology.
[3] P. W. Jones,et al. Can pre‐operative computed tomography predict resectability of ovarian carcinoma at primary laparotomy? , 2002, BJOG : an international journal of obstetrics and gynaecology.
[4] E. Fishman,et al. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography , 2000, Cancer.
[5] E. Venkatraman,et al. The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma. , 2000, Gynecologic oncology.
[6] B. McNeil,et al. Diagnosis and staging of ovarian cancer: comparative values of Doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis--report of the Radiology Diagnostic Oncology Group. , 1999, Radiology.
[7] Mcguire Wp,et al. Chemotherapy of advanced ovarian cancer. , 1998 .
[8] D. Chi,et al. The role of surgery in the management of ovarian cancer: primary and interval cytoreductive surgery. , 1998, Seminars in oncology.
[9] E. Trimble,et al. Patterns of care for women with ovarian cancer in the United States. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] K. Hatch,et al. Neoadjuvant chemotherapy for advanced ovarian cancer , 1996, International Journal of Gynecologic Cancer.
[11] H. Hricak,et al. Ovarian cancer: staging with CT and MR imaging. , 1995, Radiology.
[12] R. Zepp,et al. Ovarian carcinoma: value of CT in predicting success of debulking surgery. , 1995, AJR. American journal of roentgenology.
[13] H. Hricak,et al. Imaging of ovarian cancer , 1995, Journal of magnetic resonance imaging : JMRI.
[14] R. Yancik,et al. Cancer in older persons. Magnitude of the problem‐how do we apply what we know? , 1994, Cancer.
[15] J. Berek,et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. , 1994, American journal of obstetrics and gynecology.
[16] R. Makuch,et al. Neoadjuvant chemotherapy for advanced ovarian cancer , 1994, Gynecologic oncology.
[17] B. Sevin,et al. National survey of ovarian carcinoma part V. The impact of physician's specialty on patients' survival , 1993, Cancer.
[18] K. Swenerton,et al. Ten-year outcome of patients with advanced epithelial ovarian carcinoma treated with cisplatin-based multimodality therapy. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] E. Yordan,et al. Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] J. Berek,et al. Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] F. Naftolin,et al. Tamoxifen in combination with cytotoxic chemotherapy in advanced epithelial ovarian cancer. A prospective randomized trial , 1989, Cancer.
[22] T. Fleming,et al. Comparison of cyclophosphamide plus cisplatin versus hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin in combination as initial chemotherapy for stage III and IV ovarian carcinomas. , 1985, Cancer treatment reports.
[23] Griffiths Ct. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. , 1975 .
[24] P. Schwartz. Cytoreductive surgery for the management of stage IV ovarian cancer. , 1997, Gynecologic oncology.
[25] P. Schwartz,et al. Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.